At the present time, 430 drugs are known to cause respiratory injury. This represents an increase of almost 200 in the last ten years, and the number is still increasing. This comprehensive, definitive reference work, with an outstanding range of international expert contributors and two of the world's leading editors, provides an essential reference for the practising respiratory physician.
Key features:
The text builds upon basics with a review of basic sciences.
The book covers imaging, varied drug-induced interstitial lung disease including pulmonary edema and diffuse alveolar hemorrhage, acute respiratory failure, pleural involvement and upper to lower airway disease
A wide range of diseases are detailed from chemotherapy and radiation to biologic-induced lung disease, drug misuse, and special groups such as recipients of stem cell and solid organ transplants.
A range of world class contributions from key opinion leaders.
This book provides essential information for recognizing and managing drug-induced respiratory disease for all pulmonologists and respiratory care physicians. It will be of great interest to: critical care medicine specialists, hematologists, oncologists, cardiologists, allergists, rheumatologists, neurologists, internists, blood-bank specialists, pathologists and primary care physicians.
GENERAL: Classification, diagnosis, and management of drug-induced respiratory disease. Mechanisms of chemically induced respiratory toxicities. Imaging of drug-induced lung disease. Bronchoalveolar lavage in drug-induced lung disease. Pathology of drug-induced respiratory disease. Drug allergy in lung disease. DRUG-INDUCED RESPIRATORY EMERGENCIES: Drug-induced upper airway obstruction. Drug-induced bronchospasm. Drug-induced pulmonary oedema and acute respiratory distress syndrome. Pulmonary complications of blood transfusion. Drug-induced alveolar haemorrhage. Pulmonary complications of illicit drug use. Iatrogenic tracheobronchial and chest injury. ONCOLOGY AND ALLIED CONDITIONS: Pulmonary reactions to chemotherapeutic agents: The 'chemotherapy lung'. Pulmonary reactions to novel chemotherapeutic agents and biomolecules. Radiation-induced lung disease. Pulmonary complications of bone-marrow and stem-cell transplantation. Pulmonary complications of solid-organ transplantation. Pulmonary infection induced by drugs. Therapy-induced neoplasms. NON-ONCOLOGICAL CONDITIONS: Pneumonitis induced by non-cytotoxic agents. Amiodarone pulmonary toxicity. Eosinophilic pneumonia induced by drugs. Bronchiolitis obliterans organizing pneumonia induced by drugs or radiotherapy. Coughing induced by drugs. Pleural disease induced by drugs. Lupus erythematosus syndrome induced by drugs. Vasculitis induced by drugs. Pulmonary hypertension induced by drugs and toxins. Respiratory involvement from herbals.
Philippe Camus, MD Professor of Pulmonary Medicine, Department of Pulmonary and Critical Care Medicine, Hôpital du Bocage and Université de Bourgogne, Dijon, France Edward C Rosenow III, MD, MS, MACP, Master FCCP Emeritus Professor of Medicine, Former Chair Division of Pulmonary and Critical Care Medicine, Mayo Distinguished Clinician, Mayo Clinic School of Medicine, Rochester, Minnesota, USA
